The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)

计划入组 6 人 · 首次发布于 2024 年 5 月 14 日

Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)

计划入组 108 人 · 首次发布于 2021 年 12 月 14 日

A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

计划入组 70 人 · 首次发布于 2021 年 4 月 30 日

MRG008

PR0001

TRS007

Dual-Payload ADCs Enter Clinical Testing as Innovent and Chengdu Kanghong Pioneer Next-Generation Cancer Therapeutics

Synairgen Advances SNG001 Towards Phase II Trial for COPD

Resolution Therapeutics Expands RTX001 Liver Disease Trial to Spain